I think what has become obviouser and obviouser is that the "proprietary" stuff of the company is not that strong, else some player would have picked up the company (buyout) or supported it with a strong partnership. That is obvious, and more recently say the last year so, we also have the curiouser and curiouser, a touted trial which actually shows some positive results, with positive comments from the company, and then ...... nothing.
On biotech, I will say this, betting on anything cancer with a startup biotech is always a real gamble, regardless of the quality of the players behind it. Oh, and I've never made big money on any biotech that's gotten to high success, only on those where some hype has followed. On science, even the guys who are on the forefront fail more often than succeed, which should be a lesson for any retail investor. I'm not a science guy, but I'm a pretty good reader (economist, statistics, econometrics, finance), and it is clear to me that picking winners is a lot of luck. Here we have T. Barton, apparently made a lot shorting biotech, and in doing so, learned a lot -- but not enough to find a sure winner.
Good day here today. August 21 high was 22, I'm looking for this to hit 20 cents if this move follows through. And I might sell 25 percent or so if it does. But I've not that many shares (a bit over 150K) so I might hold, let's see this may change my life a bit if it gets to $100 or so and that is not going to happen. Just hit 71 years, and this is the last of my biotechs, it is hard stuff and the fun of it well there's other fun stuff in life also.